Zobrazeno 1 - 10
of 24
pro vyhledávání: '"Zoltan, Szilvassy"'
Autor:
Ignac Ovari, Gabor Viczjan, Tamas Erdei, Barbara Takacs, Vera Tarjanyi, Judit Zsuga, Miklos Szucs, Zoltan Szilvassy, Bela Juhasz, Rudolf Gesztelyi
Publikováno v:
Frontiers in Pharmacology, Vol 15 (2024)
The receptorial responsiveness method (RRM) enables the estimation of a change in concentration of an (even degradable) agonist, near its receptor, via curve fitting to (at least) two concentration-effect (E/c) curves of a stable agonist. One curve s
Externí odkaz:
https://doaj.org/article/972b6fd40489411ea1af45c47d01b30c
Autor:
Gabor Viczjan, Anna Szilagyi, Barbara Takacs, Ignac Ovari, Reka Szekeres, Vera Tarjanyi, Tamas Erdei, Vanda Teleki, Judit Zsuga, Zoltan Szilvassy, Bela Juhasz, Balazs Varga, Rudolf Gesztelyi
Publikováno v:
Frontiers in Pharmacology, Vol 13 (2022)
Cannabidiol (CBD), the most extensively studied non-intoxicating phytocannabinoid, has been attracting a lot of interest worldwide owing to its numerous beneficial effects. The aim of this study was to explore the effect that CBD exerts on the adenos
Externí odkaz:
https://doaj.org/article/bcba8b436b4d4d11859545dfaf32956f
Autor:
Reka Szekeres, Daniel Priksz, Rita Kiss, Dana Diana Romanescu, Mariann Bombicz, Balazs Varga, Rudolf Gesztelyi, Anna Szilagyi, Barbara Takacs, Vera Tarjanyi, Beata Pelles-Tasko, Ildiko Forgacs, Judit Remenyik, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
International Journal of Molecular Sciences, Vol 24, Iss 17, p 13253 (2023)
This study evaluates the potential therapeutic effects of anthocyanin-rich Prunus cerasus (sour cherry) extract (PCE) on atherosclerosis-associated cardiac dysfunction, described by the impairment of the NO-PKG (nitric oxide–protein kinase G) pathw
Externí odkaz:
https://doaj.org/article/fe8bc67d702b464da9c69f844b6d49c0
Autor:
Brigitta Bernat, Rita Erdelyi, Laszlo Fazekas, Greta Garami, Reka Maria Szekeres, Barbara Takacs, Mariann Bombicz, Balazs Varga, Fruzsina Sarkany, Arnold Peter Raduly, Dana Diana Romanescu, Zoltan Papp, Attila Toth, Zoltan Szilvassy, Bela Juhasz, Daniel Priksz
Publikováno v:
Pharmaceuticals, Vol 16, Iss 3, p 359 (2023)
Multi-target drug candidate BGP-15 has shown cardioprotective and antiarrhythmic actions in diseased models. Here, we investigated the effects of BGP-15 on ECG and echocardiographic parameters, heart rate variability (HRV), and arrhythmia incidence i
Externí odkaz:
https://doaj.org/article/7ca9d4e1689c4d959f45995e5fae7db7
Autor:
Mate Kozma, Mariann Bombicz, Balazs Varga, Daniel Priksz, Rudolf Gesztelyi, Vera Tarjanyi, Rita Kiss, Reka Szekeres, Barbara Takacs, Akos Menes, Jozsef Balla, Gyorgy Balla, Judit Szilvassy, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
Pharmaceutics, Vol 14, Iss 2, p 226 (2022)
Impaired mitochondrial function is associated with several metabolic diseases and health conditions, including insulin resistance and type 2 diabetes (T2DM), as well as ageing. The close relationship between the above-mentioned diseases and cardiovas
Externí odkaz:
https://doaj.org/article/59ec1d1f0609496493136e0a9a3f49f7
Autor:
Gabor Viczjan, Tamas Erdei, Ignac Ovari, Nora Lampe, Reka Szekeres, Mariann Bombicz, Barbara Takacs, Anna Szilagyi, Judit Zsuga, Zoltan Szilvassy, Bela Juhasz, Rudolf Gesztelyi
Publikováno v:
International Journal of Molecular Sciences, Vol 22, Iss 18, p 9831 (2021)
In previous studies using isolated, paced guinea pig left atria, we observed that FSCPX, known as a selective A1 adenosine receptor antagonist, paradoxically increased the direct negative inotropic response to A1 adenosine receptor agonists (determin
Externí odkaz:
https://doaj.org/article/f14ed653a36e41fe834c268f95691c8f
Autor:
Zsanett Blaga, Peter Czine, Barbara Takacs, Anna Szilagyi, Reka Szekeres, Zita Wachal, Csaba Hegedus, Gyula Buchholcz, Balazs Varga, Daniel Priksz, Mariann Bombicz, Adrienn Monika Szabo, Rita Kiss, Rudolf Gesztelyi, Dana Diana Romanescu, Zoltan Szabo, Miklos Szucs, Peter Balogh, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
International Journal of Environmental Research and Public Health; Volume 20; Issue 2; Pages: 1270
The COVID-19 pandemic has posed a huge challenge to the world in recent years. The development of vaccines that are as effective as possible and accessible to society offers a promising alternative for addressing the problems caused by this situation
Autor:
Adrienn Monika Szabo, Tamas Erdei, Gabor Viczjan, Rita Kiss, Judit Zsuga, Csaba Papp, Akos Pinter, Bela Juhasz, Zoltan Szilvassy, Rudolf Gesztelyi
Publikováno v:
Molecules, Vol 24, Iss 12, p 2207 (2019)
In earlier studies, we generated concentration-response (E/c) curves with CPA (N6-cyclopentyladenosine; a selective A1 adenosine receptor agonist) or adenosine, in the presence or absence of S-(2-hydroxy-5-nitrobenzyl)-6-thioinosine (NBTI, a selectiv
Externí odkaz:
https://doaj.org/article/4605fac544fd4647b73400863549dac5
Autor:
Mariann Bombicz, Daniel Priksz, Rudolf Gesztelyi, Rita Kiss, Nora Hollos, Balazs Varga, Jozsef Nemeth, Attila Toth, Zoltan Papp, Zoltan Szilvassy, Bela Juhasz
Publikováno v:
Molecules, Vol 24, Iss 3, p 586 (2019)
Background and Aims: Diabetic cardiomyopathy (DCM) is an emerging problem worldwide due to an increase in the incidence of type 2 diabetes. Animal studies have indicated that metformin and pioglitazone can prevent DCM partly by normalizing insulin re
Externí odkaz:
https://doaj.org/article/508c1c643b854f6ca9591bdf9e75b339
Autor:
Juhasz, Mate Kozma, Mariann Bombicz, Balazs Varga, Daniel Priksz, Rudolf Gesztelyi, Vera Tarjanyi, Rita Kiss, Reka Szekeres, Barbara Takacs, Akos Menes, Jozsef Balla, Gyorgy Balla, Judit Szilvassy, Zoltan Szilvassy, Bela
Publikováno v:
Pharmaceutics; Volume 14; Issue 2; Pages: 226
Impaired mitochondrial function is associated with several metabolic diseases and health conditions, including insulin resistance and type 2 diabetes (T2DM), as well as ageing. The close relationship between the above-mentioned diseases and cardiovas